Jiangsu Hengrui Pharmaceuticals (600276.SH) has repurchased a total of 8.3245 million shares, costing 364 million yuan.

Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that as of the morning of April 9, 2025, the company has repurchased a total of 8.3245 million shares through centralized bidding trading, accounting for 0.13% of the total share capital of the company, with a total repurchase amount of 3.64 billion yuan (excluding transaction fees). Since early April, the company has repurchased a total of 1.4708 million shares, with a total repurchase amount of 70.33 million yuan (excluding transaction fees).